Increased plasma lysozyme levels and activity are found in obese subjects, the plasma lysozyme might be protective on the development of obesity-associated metabolic disturbances (Moreno-Navarrete et al., 2021). This evidence concerns the gene LYZ and obesity due to melanocortin 4 receptor deficiency.